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Undoubtedly, whole blood and vitreous humor have been biological
samples of great importance in forensic toxicology. The determin-
ation of opiates and their metabolites has been essential for better
interpretation of toxicological findings. This report describes the
application of experimental design and response surface method-
ology to optimize conditions for enzymatic hydrolysis of morphine-
3-glucuronide and morphine-6-glucuronide. The analytes (free
morphine, 6-acetylmorphine and codeine) were extracted from the
samples using solid-phase extraction on mixed-mode cartridges,
followed by derivatization to their trimethylsilyl derivatives. The
extracts were analysed by gas chromatography–mass spectrometry
with electron ionization and full scan mode. The method was vali-
dated for both specimens (whole blood and vitreous humor). A sig-
nificant matrix effect was found by applying the F-test. Different
recovery values were also found (82% on average for whole blood
and 100% on average for vitreous humor). The calibration curves
were linear for all analytes in the concentration range of 10–
1,500 ng/mL. The limits of detection ranged from 2.0 to 5.0 ng/mL.
The method was applied to a case in which a victim presented
with a previous history of opiate use.
Introduction
The term “opiates” refers to substances derived from the
opium poppy (Papaver somniferum), such as morphine and
codeine, and also includes some semi-synthetic substances like
heroin or oxycodone. Primarily prescribed to treat acute and
chronic pain, these drugs are available in a varied number of
pharmaceutical formulations. Heroin has also medical applica-
tions in many European countries, although it is classiﬁed as a
Schedule I drug under United States law (1).
The opiates constitute a group of the most highly abused
drugs in America, Europe and Asia. Fatalities involving opiate
overdose have increased dramatically in the past few years.
Heroin abuse is one of the major drug problems in society. In
addition to the cases of overdose, incidental or negligent cases
of death involving opiates, medical care and treatment have
also been reported (2). Postmortem blood with an elevated
morphine concentration was detected in a reported and
curious case involving children who were withdrawn from life
support, which emphasized the need for toxicological analysis
in an attempt to solve these cases (3). The analysis and inter-
pretation of opiates in postmortem specimens can present
special challenges to the forensic toxicologist.
Morphine is primarily metabolised by glucuronidation to
morphine-3-glucuronide (M3G) and morphine-6-glucuronide
(M6G), which may be found in large concentrations in the
plasma due to the enterohepatic recycling. The pharmacological
activity of M6G reaches levels that are even higher than mor-
phine following oral administration, whereas M3G has little afﬁn-
ity for opioid receptors, but may also contribute to excitatory
effects (4). If some time has passed after exposure, these meta-
bolites can reach signiﬁcant concentrations in biological speci-
mens, and therefore, the concentrations of free and total
morphine should be analyzed. Acid and enzymatic hydrolysis
procedures for measuring total morphine have been reported, al-
though inaccurate results or incomplete hydrolysis have been
demonstrated (5).
Codeine analgesic activity is displayed by its metabolism to
morphine and its glucuronides (6). Heroin is quickly metabo-
lized to 6-acetylmorphine (6-AM), and the main metabolite de-
tection allows the statement of heroin ingestion. However,
6-AM is also rapidly metabolized to morphine, which can make
its detection difﬁcult in many cases (7). This metabolite is un-
stable in blood samples due to conversion to morphine by the
action of esterases. The stability of these substances is also
inﬂuenced by pH. Therefore, the analysis of vitreous humor
can be of great importance to better interpret heroin-related
deaths. In the eye, there is a lack of enzymes, which preserves
the integrity of 6-AM. This has been demonstrated in some
cases in which 6-AM was present in the vitreous humor and
absent in the blood (8). The addition of sodium ﬂuoride preser-
vative (2%) to the samples showed a signiﬁcant increase in
6-AM stability owing to the inhibition of bacterial action (9).
The primary biotransformation pathways of opiates are shown
in Figure 1.
Vitreous humor is composed of 99% water, with the remain-
ing 1% made up of sugar, salts and proteins. It is also subjected
to less contamination and bacterial degradation due to the pro-
tected environment inside the eye, which makes it available for
analysis in cases in which blood samples have already been
degraded (10).
The quantitative methods for the determination of opiates in
postmortem specimens have been described in the scientiﬁc
literature. The use of gas chromatography–mass spectrometry
(GC–MS) (11–14) and liquid chromatography–mass spectrom-
etry (LC–MS) (15–17) has been reported by several authors.
The most commonly used sample preparation techniques have
included liquid–liquid extraction (13, 14) and solid-phase ex-
traction (SPE) procedures (11, 12, 15–17).
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Despite all the available methods for the determination of
opiates in biological samples, the conditions for glucuronide
hydrolysis (which can be enzymatic or by means of addition of
strong acids) have varied widely among these methods, and
there is still a lack of information concerning the efﬁciency of
these procedures (12, 13, 18, 19). Another point to be consid-
ered is the evaluation of the matrix effect for the quantiﬁcation
of substances in different biological specimens, a common situ-
ation in forensic toxicology. Therefore, the objective of this
work was to optimize enzymatic hydrolysis conditions by
means of experimental design and provide validation data to
quantify opiates (total and free morphine, 6-AM and codeine)
in whole blood and vitreous humor, also considering the pos-
sible matrix effect. The validated method was applied to a case
in which the victim presented with a previous history of opiate
use.
Experimental
Chemicals and reagents
Morphine, codeine, 6-AM, morphine-3bd-glucuronide,
morphine-6bd-glucuronide and the deuterated internal stand-
ard morphine-d3 were purchased from Cerilliant (Round Rock,
TX) as solutions in methanol or acetonitrile at a concentration
of 1 mg/mL or 100 mg/mL. b-Glucuronidase from Helix
Pomatia (type H-1) 500 KU and N,O-bis-(N,O-trimethylsilyl) tri-
ﬂuoroacetamide (BSTFA) with 1% of TCMS were obtained from
Sigma Aldrich (St. Louis, MO). Bond Elut Certify SPE cartridges
(130 mg) were obtained from Varian Inc. (Palo Alto, CA). All
other solvents and reagents of analytical grade were supplied
by Merck (Darmstadt, Germany).
Specimens
The drug-free blood samples were obtained from non-user
volunteers (laboratory staff) and were collected in gray-top
tubes containing 2% of sodium ﬂuoride and stored at –208C.
Due to similarities in chemical composition, a saline solution
(1% NaCl) was used as drug-free vitreous humor. The drug-free
samples were used for the validation process of the analytical
methods. The case samples (blood and humor vitreous) were
obtained from a body attended by the Death Veriﬁcation
Service at the University of Sa˜o Paulo, Brazil. These samples
were also collected in gray-top tubes containing 2% of sodium
ﬂuoride. This study was approved by the Research Ethics
Committee of the Clinics Hospital at the Faculty of Medicine of
University of Sa˜o Paulo – CAPPesq HC-FMUSP (Ethics Protocol
Approval number 0352/09).
Extraction and derivatization
One milliliter of each sample (whole blood or vitreous humor)
was mixed with 10 mL of a 10 mg/mL internal standard solution
(morphine-d3) and 5.0 mL of a 0.1M phosphate buffer solution
(pH 6.0) in a 15-mL cap tube. The mixture was vortexed and
centrifuged for 12 min at 300 g, and the supernatant was
placed on SPE columns. The SPE cartridges were conditioned
with 2 mL of methanol, followed by 2 mL of 0.1M phosphate
buffer (pH 6.0). Following conditioning, the samples were
added to the cartridges and allowed to ﬂow under gravity.
Then the columns were washed by the sequential addition of
2.0 mL of deionized water, 1.0 mL of 0.1M acetate buffer
(pH 4.0) and 2.0 mL of methanol; they were then dried under
maximum vacuum for 2 min. The analytes were eluted with
Figure 1. The primary biotransformation pathways of opiates.
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2.0 mL of a fresh dichloromethane–isopropanol–ammonium
hydroxide solution (20:5:0.5 v/v/v) and collected in 3.0-mL
conical-shaped vials. Each sample eluent was evaporated under
a stream of nitrogen at 408C. The residue was reconstituted in
50 mL of BSTFA þ 1% of TCMS, capped, vortexed and heated
for 20 min at 708C. After cooling, the solution was transferred
to autosampler vials, and 1 mL of the solution was injected into
the GC–MS system.
For the determination of total morphine, the enzymatic hy-
drolysis was performed using b-glucuronidase from Helix
Pomatia (type H-1). The lyophilized enzyme was reconstituted
with 1.0M acetate buffer (pH 5.0) to yield 100.000 units/mL
b-glucuronidase activity. Then, a second aliquot of 1.0 mL of
each sample (whole blood or vitreous humor) received 10 mL
of a 10 mg/mL internal standard solution (morphine-d3),
1.0 mL of 1.0 M acetate buffer (pH 5.0) and 200 mL of the
H. Pomatia b-glucuronidase solution. The tubes were vortexed
and incubated at 378C for 4 h. After hydrolysis and cooling to
room temperature, 5.0 mL of 0.1M phosphate buffer (pH 6)
was added to each tube and samples were submitted to the
same SPE procedure described previously.
Instrumentation
The quantitative analysis was performed on a Focus GC coupled
to a Polaris Q ion trap MS from Thermo Scientiﬁc (Waltham,
MA), which was operated in the electron ionization mode. The
chromatographic separation was achieved using an HP-5MS
fused-silica capillary column (30 m  0.25 mm i.d., 0.25 mm ﬁlm
thickness). Helium was the carrier gas, which was set at a ﬂow
rate of 0.7 mL/min. The injector was operated in the splitless
mode at 2708C, and the transfer line temperature was set at
2808C. The GC oven was initially held at 1508C for 1 min, with a
ramp of 108C/min to 2508C (held 8 min). Full scan analyses
were performed in the mass range of 200–500 m/z. The accept-
ance criteria of qualiﬁcation were: retention time within 2%
compared with standards analyzed in the same batch, and the
mass spectrum should have a good visual match to that of the
standards. The monitored ions for quantiﬁcation of analytes
were as follows: morphine, m/z (429); morphine-d3, m/z (432);
codeine, m/z (371); 6-acetylmorphine, m/z (399).
The experimental design for the optimization of the
enzymatic hydrolysis conditions for morphine
glucuronides
The optimization study was conducted using a multivariate
statistical technique called response surface methodology
(RSM), which made statistical previsions based on the ﬁt of a
polynomial equation to the experimental data (20). The appli-
cation of this methodology made it possible to simultaneously
optimize the levels of the variables, which allowed us to
observe the interactive effects among them.
An experimental design called Box-Behnken was chosen to
deﬁne which experiments should be performed before the ap-
plication of the RSM methodology. Box-Behnken is a three-level
factorial design that requires only 17 experiments, in which
ﬁve of them are replicates of the center point (21).
The enzymatic hydrolysis was performed using
b-glucuronidase from Helix Pomatia (type H-1). The three factors
that were analyzed with signiﬁcant relevance and chosen levels
(low and high) were as follows: incubation temperature (37–
608C), incubation time (4–24 h) and enzyme concentration
(2,500–20,000 units/mL). The experiments were conducted in
random order to provide an accurate estimation of the experi-
mental error. The fortiﬁed blood samples (1.0 mL) with a total
concentration of 1,000 ng/mL of the glucuronides were sub-
jected to the selected conditions (temperature, time and enzyme
concentration) and analyzed according to the procedure
described previously. Analysis of variance was applied to the re-
gression results, which veriﬁed whether a lack of ﬁt was evident.
The ratio between the morphine and morphine-d3 peak
areas was used as the response. Design-Expert (version 8), a
statistical software, was used to select the experimental design
and to perform the analysis through the application of response
surface methodology.
Method validation
The method was validated by determining sensitivity, selectiv-
ity, linearity, extraction efﬁciency, precision (intra-assay and
inter-assay) and stability. To obtain the validation data, quality
control (QC) samples were prepared by spiking drug-free
matrices, which resulted in the following concentrations of
morphine, 6-AM and codeine: 30, 550 and 1,100 ng/mL (QC1,
QC2 and QC3). All parameters were analyzed in both the blood
and saline solutions.
The limit of detection and the limit of quantitation
The limit of detection (LOD) was deﬁned as the concentration
giving a signal to noise ratio of .3. The limit of quantitation
(LOQ) was deﬁned as the concentration giving a signal to noise
ratio of .10. LOD and LOQ should still satisfy the predeter-
mined acceptance criteria of qualiﬁcation (retention time within
2% compared with standards analyzed in the same batch and a
good visual match of mass spectrum to that of the standards).
Selectivity (matrix effects)
The interfering compounds present in each matrix may
strengthen or reduce the detection of the analytes of interest,
which can lead to different results from the analysis of fortiﬁed
samples with the same analyte concentration, but in different
matrices (22). This assay was performed to identify the differ-
ences in analyte detection caused by different matrix effects of
the blood and saline solutions. The test was performed by pre-
paring two sets of samples (n ¼ 6): one contained blood, and
the other contained a saline solution, and both samples had the
same concentration of analytes at each target concentration
level (30, 550 and 1,100 ng/mL). Data were analyzed by the ap-
plication of the F-test to test for differences among sample vari-
ance, followed by the application of the t-test to assess
whether the means of the two groups were statistically differ-
ent from each other (Eq. 1).
Fcal ¼ s21=s22 ð1Þ
In this equation, s1 and s2 represent the standard deviations of
the analyte response for each set of samples, and the larger
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variance should be used as the nominator. Fcal represents the
calculated value of F, while Ftab represents the tabulated value.
If Fcal , Ftab, the F-test is not signiﬁcant (5% signiﬁcance
level), and it can be considered that the variances are similar.
Then, the difference of the means of the two groups can be
tested with Student’s t-test (Eqs. 2 and 3).
tcal ¼ x1  x2jjﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
s2
1
n1
þ 1
n2
 s ð2Þ
s2 ¼ n1  1ð Þs
2
1 þ n2  1ð Þs22
n1 þ n2  2ð Þ ð3Þ
In these equations, x1 and x2 represent the means of the
analyte response for each set of samples; n1 and n2 represent
the number of replicates in each set of samples; tcal represents
the calculated value of t, while ttab represents the tabulated
value from the Student’s t-distribution.
On the other hand, if Fcal . Ftab, the F-test is signiﬁcant,
which means that the variances between the groups are differ-
ent; then, the t-test of unequal variances can be used to test
the means (23) (Eqs. 4 and 5).
tcal ¼ xd
ﬃﬃﬃ
n
p
sd
ð4Þ
xd ¼
Xn
i¼1
di1  di2ð Þ
n
ð5Þ
In these equations, di1 and di2 are the responses for a sample
pair in each group, xd represents the mean of differences
between analyte response pairs, sd represents the standard de-
viation of differences between them and n is the number of
pairs.
If the calculated t value (for equal or unequal variances) is
below the value that is expected in the t-test tables, it is pos-
sible that the analytes do not suffer a different interference
from the matrices and vice versa.
Linearity
The linearity study was performed by analyzing the blood and
saline solutions that were fortiﬁed with morphine, 6-AM and
codeine standards to obtain the concentrations of 10, 50, 150,
350, 750 and 1,500 ng/mL. A deuterated internal standard
(morphine-d3) was added at a concentration of 100 ng/mL.
Calibration curves were obtained by plotting the peak area
ratios (analyte/internal standard) against the concentrations,
and the linearity, which was expressed as the correlation coef-
ﬁcient (r2), was obtained. The test for homoscedasticity was
veriﬁed by applying the F-test, which was expressed as the
ratio between the variances obtained at the lowest and the
highest concentration level of the dynamic range. If Fcal was
lower than Ftab (f1, f2; 0.99), then the variance was constant
over the entire calibration curve and was considered homosce-
dastic. Weighted least square linear regressions can be used
when heteroscedasticity is detected (24).
Extraction efﬁciency—Recovery
The extraction efﬁciency was determined using the QC samples
at the target concentrations of 30, 550 and 1,100 ng/mL for all
analytes. The recovery study was performed by preparing one
set of samples that were fortiﬁed with a control solution at the
initial time of sample preparation before SPE and by preparing
another set of samples that were only fortiﬁed after extraction
but before evaporation and derivatization. The relative recovery
was calculated by comparing the mean response in the ﬁrst
group (extracted) to the mean response of the second group
(non-extracted) and then multiplying by 100.
Precision (intra- and inter-assay)
The precision assay was performed by the analysis of replicate
blood and saline samples (n ¼ 6) at the target analyte concen-
trations of 30, 550 and 1,100 ng/mL. The intra-assay precision
for the samples was determined on the same day and per-
formed within one analytical run, while the inter-assay preci-
sion for the samples was determined on three different days.
Data were evaluated through the analysis of variance in each
group (intra-assay and inter-assay), which was established by
the relative standard deviation (RSD%).
Stability
The handling of the samples and different storage conditions
can inﬂuence analyte stability. The stability assay was assessed
using blood and saline solutions fortiﬁed with analytes of inter-
est at low and high concentrations (30 and 1,100 ng/mL). The
storage conditions studied were as follows: room temperature
for 24 h, 48C for 7 days, –208C followed by thawing at room
temperature (three freeze-thaw cycles) and –208C for three
months. Analyses were performed in triplicate for each condi-
tion and level of concentration. In this assay, the stability of
morphine, 6-AM and codeine along with M3G and M6G was
determined to verify the occurrence of the natural hydrolysis
of these metabolites to morphine. The concentrations obtained
in the QC samples after each storage condition were compared
to those from freshly prepared QC samples. Acceptable results
included a maximum concentration difference of 20% when
comparing QC samples under storage with fresh QC samples.
Case study
To prove the applicability of this analytical method, a case that
involved opiate consumption was analyzed. The quantiﬁcation
was based on the ratios of the ion peak areas of the com-
pounds to the internal standard ion peak areas. The calibration
curves were used to determine the opiate concentrations,
which used a weighting factor of 1/x2 for blood and 1/y2 for
vitreous humor.
A woman who was approximately 80 years old and had
traces of cancer in the liver was examined at the Death
Veriﬁcation Service, University of Sa˜o Paulo, Brazil. A rapid im-
munoassay test for drugs (Triage, Biosite) in the urine was used
at the autopsy and was positive for opiates. No other details
about the history of the case were accessed.
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Results and Discussion
GC–MS analyses
Opiates have often been found in postmortem biological ﬂuids
in overdose cases or even in cases of treatment with legitimate
prescriptions. Gas chromatographic analysis of these sub-
stances has been difﬁcult due to their high polarity and low
volatility. It has been necessary to apply derivatization techni-
ques to produce thermal and volatile stable derivatives (25). In
this study, the silylation derivatizing technique was chosen
because it is one of the most commonly applied techniques. It
is easy to use and does not require additional solvent or
clean-up steps. Good reproducibility was obtained using this
technique.
All analytes were successfully extracted and separated using
this method. All ion peaks were Gaussian-shaped and demon-
strated baseline resolution. The molecular ion was usually the
most abundant in the mass spectra of opiate-TMS derivatives;
therefore, it was selected as the quantiﬁcation ion.
Optimisation of the enzymatic hydrolysis conditions of
morphine glucuronides
The morphine glucuronides are very important analytes to be
detected in toxicological analysis. Nevertheless, because of its
extreme polarity, it is necessary to include a hydrolysis step,
which enables the determination of total morphine by gas
chromatography.
Good glucuronide hydrolysis rates in urine have been
reported in the literature with acid hydrolysis (26, 27), which
is even faster than the enzymatic process. However, this drastic
condition can convert some opiates such as 6-AM or acetylco-
deine into morphine or codeine, which overestimates the con-
centrations. Therefore, we opted for the enzymatic hydrolysis,
which used b-glucuronidase.
To obtain optimal conditions for the hydrolysis of glucuro-
nides, some parameters such as the incubation time, incubation
temperature and enzyme concentration of b-glucuronidase from
Helix Pomatia were evaluated. The response surface method-
ology was used to perform the optimisation. This technique sim-
ultaneously optimized the levels of variables, which enabled us
to observe the interactive effects between the variables, to
reduce the number of experiments necessary to conduct the re-
search, and to decrease the time and expenses consumed when
compared to the traditional one-variable-at-a-time optimization
technique. Box-Behnken was chosen as the experimental design
because it seemed to be the most efﬁcient and economical
three-level factorial design, requiring only 17 experiments (21).
Costa et al. (28) have also applied the design of experiments
technique to perform the optimization of urinary morphine glu-
curonide hydrolysis; however, the procedure was performed
with strong acids instead of enzymes, and only M3G hydrolysis
was focused on in the study. M6G does not seem to be as
readily hydrolyzed as M3G. In fact, M6G has glucuronide acid
bound to an alcoholic position, whereas in M3G, glucuronide
acid is bound to a phenolic position, which is electron-rich. This
position facilitates the hydrolysis due to the formation of a phe-
nolate anion that can be stabilized through resonance (29).
No reports have related the optimization methods of mor-
phine glucuronide hydrolysis in blood samples. The vast
majority of the studies have compared the difference between
the acid and enzymatic hydrolysis conditions only in urine
samples (27, 29, 30), almost always reporting better hydrolysis
rates with the acid condition. Hackett et al. (27) reported that
more than 90% of M3G is hydrolyzed in urine samples, with an
incubation time of 4 or 24 h at 608C with b-glucuronidase
from H. Pomatia or at 458C with b-glucuronidase from E. coli,
whereas the use of acid hydrolysis resulted in the conversion
of 95% of morphine glucuronide to morphine. The conditions
for the hydrolysis of morphine glucuronides in blood, such as
1 h of incubation at 608C with 2 mL of b-glucuronidase (31) or
16 h of incubation at 378C with 5,000 U/mL of b-glucuronidase
(13), were also reported in the scientiﬁc literature; however,
the efﬁciency of these procedures was not mentioned.
Our results showed that the optimal condition for hydrolysis
is 4 h of incubation at 378C with the addition of 20.000 U/mL
of b-glucuronidase, which results in hydrolysis efﬁciency rate
of 75% (Figure 2). A progressive increase in efﬁciency was
observed when the amount of enzyme was increased. A de-
crease in the hydrolysis rate occurred when the incubation
temperature was increased, which was probably because of en-
zymatic degradation at high temperatures. The best efﬁciencies
of hydrolysis were obtained using incubation times of 4 and
Figure 2. Response surfaces of the conditions studied to the enzymatic hydrolysis
of morphine glucuronides. Response area as function of temperature of incubation
(8C) and enzyme concentration (U/mL) at a time of 4 h (A). Response area as
function of time (h) and temperature of incubation with an enzyme concentration of
20,000 U/mL (B).
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24 h. From this, it was found that 4 h are enough to complete
the hydrolysis, and this time was selected to perform the
enzyme incubation. The blood samples with and without
sodium ﬂuoride were tested to assess the enzymatic hydrolysis
efﬁciency; no signiﬁcant differences were found.
The analysis of variance showed that the regression model is
signiﬁcant (p ¼ 0.016), and no signiﬁcant lack of ﬁt was found
(p . 0.05).
Extraction procedure
The amphoteric nature of morphine has made it difﬁcult to use
some extraction procedures, such as liquid–liquid extraction,
because it forms charged species at all pHs other than its isoe-
letric point, which makes it water soluble and difﬁcult to
extract, resulting in poor recovery. The use of SPE with cation
exchange columns has improved the efﬁciency of extracting
drugs such as morphine because it has allowed the drug to be
extracted in the charged form.
Additionally, concerning SPE extraction, the difﬁculty
encountered, also reported in literature (32), is related to the
passage of postmortem blood through the SPE columns; this
specimen is often clotted and not homogenous, easily plugging
the column. Hence, the samples were diluted ﬁve-fold in buffer
and centrifuged before extraction, which enabled a smooth
passage through the cartridges and did not compromise the
quantitative determination.
The employment of vitreous humor to analyze drugs can be
of great importance because it is a clean matrix; it is composed
of 99% water and contains few proteins and enzymes (10).
Method validation
The results obtained in the method validation for the determin-
ation of opiates in blood and saline solution samples are shown
in Table I.
A matrix effect study (selectivity test) was performed to
verify the necessity of validating the method in both matrices.
Some laboratories have not tested the matrix effect and have
only used blood calibration curves to quantify vitreous humor
samples. In fact, Antonides et al. (33) have not observed any
signiﬁcant variability in vitreous humor concentration quanti-
ﬁed using calibrators prepared in blood matrix, and the com-
parison between the measurement of vitreous values using a
calibration curve in the blood matrix and in the vitreous matrix
resulted in a difference of no more than 20% of their averages.
In the present study, however, the analysis of the variances and
the means obtained between the blood and saline solution sets
of samples showed a signiﬁcant difference in analyte responses
at all concentration levels (30, 550 and 1,100 ng/mL). Hence,
all the conﬁdence parameters were obtained in both matrices,
and we recommend that the calibration curves for the analysis
of case samples should be performed in each speciﬁc matrix,
which minimizes errors.
The LODs were 5.0 ng/mL in the blood samples and 2.0 ng/
mL in the saline samples for all the analytes. The LOQ was
10.0 ng/mL in both the blood and saline samples for all the
opiates. These limits were considered to be good values that
compared well with previously published work.
The linear dynamic range was determined based on the
opiates’ therapeutic and fatal concentrations and in addition to
previous works; these values ranged from 10 to 1,500 ng/mL.
The method showed that the data were heteroscedastic, which
was probably attributable to the large concentration range
(two orders of magnitude). In this case, the larger deviations
that were present at higher concentrations tended to inﬂuence
the linear regression more than the smaller deviations that
were present at smaller concentrations, which can impair the
accuracy in the lower part of the range (23). Weighted least
square linear regression was applied in this case, which
decreased the sum of the relative error percentages over the
entire range. The correlation coefﬁcients for the calibration
curves were all greater than 0.995 for the blood samples when
a weighting factor of 1/x2 was used (morphine: y ¼ 0.0062x þ
0.0019; 6-AM: y ¼ 0.0039x þ 0.0004; codeine: y ¼ 0.0025x –
0.0011), and were greater than 0.999 for the saline samples
when a weighting factor of 1/y2 was used (morphine: y ¼
0.003459x – 0.00134; 6-AM: y ¼ 0.00415x – 0.00654; codeine:
y ¼ 0.002558x – 0.00364).
The average extraction efﬁciencies ranged from 76 to 88% in
the blood samples and from 98 to 103% in the saline samples.
The recovery rates above 75% were considered good values
when considering the analysis of biological ﬂuids.
Table I
Confidence Parameters for the Opiates’ Method Validation
Blood Saline solution
Morphine 6-AM Codeine Morphine 6-AM Codeine
LOD (ng/mL) 5.0 5.0 5.0 2.0 2.0 2.0
LOQ (ng/mL) 10.0 10.0 10.0 10.0 10.0 10.0
Mean intra-assay precision (RSD%) 5.6 7.3 9.3 4.1 5.4 4.7
Mean inter-assay precision (RSD%) 6.8 4.3 8.6 3.0 6.0 2.8
Mean recovery (%) 81.2 76.4 88.6 98.3 98.6 103.3
Linearity (10–1500 ng/mL) r2 ¼ 0.9961 r2 ¼ 0.9976 r2 ¼ 0.9951 r2 ¼ 0.9998 r2 ¼ 0.9993 r2 ¼ 0.9994
Table II
Free and Total Codeine and Morphine Concentrations Found in the Real Case Samples
Morphine (ng/mL) Codeine (ng/mL)
Total Free Total Free
Femoral blood 269.9 n.d.* 1279.4 116.9
Cardiac blood 397.3 n.d. 1256.9 211.8
Vitreous humor 162.1 n.d. 798.6 341.6
*n.d.: not detected
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Figure 3. Chromatographic profile obtained with a SPE–GC–MS analysis of a fortified blood sample containing codeine (1), morphine and morphine-d3 (2, 3) and
6-acetylmorphine (4) at a middle concentration (550 ng/mL) (A). Drug-free blood sample (B). Postmortem cardiac blood hydrolyzed sample of the related case (C). Postmortem
femoral blood hydrolyzed sample of the related case (D). Postmortem vitreous humor hydrolyzed sample of the related case (E). The ions acquired to generate the
chromatograms were as follows: 429 þ 432 þ 399 þ 371.
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The inter-assay precision ranged from 4.3 to 8.5% (RSD) in
the blood samples and from 2.8 to 6.0% in the saline samples.
The intra-assay precision yielded coefﬁcients of variance that
ranged from 5.6 to 9.3% in the blood samples and from 4.1 to
5.4% in the saline samples. The use of morphine-d3 as an in-
ternal standard did not affect the reproducibility of the analysis,
with the RSDs not exceeding the predeﬁned limit of 10% for
the intra-assay precision and 20% for the inter-assay precision
for all analytes.
The investigation of opiate stability in the blood samples did
not indicate any degradation under all the conditions studied,
with the exception of 6-AM, which showed instability at room
temperature and after being stored for a long period (3 months
in freezer). With respect to analyte stability in the saline
samples, only 6-AM and codeine showed instability after being
stored for a long period. The results indicated that case
samples must be analyzed as soon as possible because the ana-
lytes can degrade after being stored for a long period. In all
storage conditions studied, neither M3G and M6G showed any
degradation to morphine, even in the blood and saline samples;
this could be a result of the sodium ﬂuoride effect, which elim-
inates bacterial contamination and inhibits enzymatic activity.
Case study
Codeine and morphine were found in the case analysis. The
drug concentrations found in samples are shown in Table II.
A high total codeine concentration was observed in all ana-
lyzed samples, which was a result of the hydrolysis of a
codeine metabolite, codeine-6-glucuronide. The deceased had
suffered from cancer and had probably received codeine treat-
ment for pain control. The free codeine concentration in the
blood was in the therapeutic range, and the higher amount
that was detected in the total form indicated chronic use.
The presence of morphine in the samples was a result of
codeine metabolism, which was explained by the lower
amounts of this drug in relation to codeine. The larger amount
was in the total form, while the free concentration was
detected only in trace amounts.
A higher concentration of free codeine was observed in the
cardiac blood than in the femoral blood. This yielded a C/F ratio
of 1.8 and indicated a possible postmortem redistribution of this
drug, which was not observed in the total concentration, possibly
because the conjugate form did not suffer this phenomenon.
With respect to the concentrations detected in the vitreous
humor samples, the concentrations of the total form of both
analytes, morphine and codeine, were lower than the blood
samples. The metabolites might have had difﬁculty crossing the
lipid barriers due to their polar character. Otherwise, the free
codeine concentration was higher in this ﬂuid, which could be
a result of the apparent delay in the drug excretion process of
the vitreous humor. The chromatographic proﬁles of a fortiﬁed
blood sample, a drug-free blood sample and the case samples
are shown in Figure 3.
Conclusions
The use of dilution followed by centrifugation and SPE enabled
us to obtain clean extracts even when working with whole
blood samples, which did not interfere with the drug quantita-
tion and eliminated the deproteination procedure steps.
The optimization of the enzymatic hydrolysis of glucuronides
facilitated more accurate and efﬁcient results for the applica-
tion of total analytes, which is of great importance to better in-
terpret opiate cases and can help establish the time of death
using the proportion of free and total analytes.
The method was validated for both specimens (whole blood
and vitreous humor) and a signiﬁcant matrix effect was found
by applying the F-test. Therefore, it is recommendable that cali-
bration curves should be performed in each speciﬁc matrix to
minimize errors.
This method ﬁt well for the purpose for which it was
intended, which was obtaining precise and accurate results for
laboratory routines.
Acknowledgments
This study was supported by the Faculty of Medicine –
University of Sa˜o Paulo (LIM 40/HC-FMUSP). Financial support
received from Fundac¸a˜o de Amparo a` Pesquisa do Estado de
Sa˜o Paulo (FAPESP grant no. 2009/08314-9 and 2010/11517-6)
and Conselho Nacional de Desenvolvimento Cientı´ﬁco e
Tecnolo´gico (CNPq grant 470643/2009-9 and 554674/2009-0)
is also gratefully acknowledged.
References
1. Jenkins, A.J. (2007) Pharmacokinetics: Drug absorption, distribu-
tion, and elimination. In Karch, S.B. (ed.), Drug abuse handbook,
2nd edition. CRC Press, Boca Raton, FL, pp. 147–205.
2. Crandall, C.S., Kerrigan, S., Aguero, R.L., Valley, J.L., McKinney, P.E.
(2006) The inﬂuence of collection site and methods on post-
mortem morphine concentrations in a porcine model. Journal of
Analytical Toxicology, 30, 651–658.
3. Watterson, J., Peaire, A., Hinman, J. (2008) Elevated morphine concen-
trations determined during infant death investigations: Artifacts of
withdrawal of care. Journal of Forensic Science, 53, 1001–1004.
4. Gutstein, H.B., Akil, H. (2006) Opioids analgesics. In Hardman, J.G.,
Limbird, L.E., Gilman, A.G. (eds.), Goodman and Gilman’s the
pharmacological basis of therapeutics, 11th edition. McGraw-Hill,
New York, NY, pp. 569–619.
5. Bosch, M.E., Sa´nchez, A.R., Rojas, F.S., Ojeda, C.B. (2007) Morphine
and its metabolites: Analytical methodologies for its determination.
Journal of Pharmaceutical and Biomedical Analysis, 43, 799–815.
6. Trescot, A.M., Datta, S., Lee, M., Hansen, H. (2008) Opioid pharma-
cology. Pain Physician, 11, 133–153.
7. Wyman, J., Bultman, S. (2004) Postmortem distribution of heroin
metabolites in femoral blood, liver, cerebrospinal ﬂuid, and vitreous
humor. Journal of Analytical Toxicology, 28, 260–263.
8. Pragst, F., Spiegel, K., Leuschner, U., Hager, A. (1999) Detection of
6-acetylmorphine in vitreous humor and cerebrospinal ﬂuid com-
parison with urinary analysis for proving heroin administration in
opiate fatalities. Journal of Analytical Toxicology, 23, 168–172.
9. Rees, K.A., Jones, N.S., McLaughlin, P.A., Osselton, M.D. (2011) The
effect of storage temperature and sodium ﬂuoride preservative on
the stability of 6-monoacetylmorphine in horse blood, vitreous
humour and muscle tissue. Forensic Science International, in press.
10.1016/j.forsciint.2011.11.001
10. Cox, D., Phipps, R.A., Levine, B. (2007) Distribution of phencyclidine
into vitreous humor. Journal of Analytical Toxicology, 31, 537–539.
11. Lewis, R.J., Johnson, R.D., Hattrup, R.A. (2005) Simultaneous ana-
lysis of Thebaine, 6-MAM and six abused opiates in postmortem
ﬂuids and tissues using Zymark automated solid-phase extraction
Determination of Opiates in Whole Blood and Vitreous Humor 169
and gas chromatography–mass spectrometry. Journal of
Chromatography B, 822, 137–145.
12. Kerrigan, S., Honey, D., Baker, G. (2004) Postmortem morphine
concentrations following use of a continuous infusion pump.
Journal of Analytical Toxicology, 28, 529–32.
13. Meatherall, R. (2005) GC–MS quantitation of codeine, morphine, 6-
acetylmorphine, hydrocodone, hydromorphone, oxycodone, and
oxymorphone in blood. Journal of Analytical Toxicology, 29,
301–308.
14. Guillot, E., Mazancourt, P., Durigon, M., Alvarez, J. (2007) Morphine
and 6-acetylmorphine concentrations in blood, brain, spinal cord,
bone marrow and bone after lethal acute or chronic diacetylmor-
phine administration to mice. Forensic Science International, 166,
139–144.
15. Al-Asmari, A.I., Anderson, R.A. (2007) Method for quantiﬁcation of
opioids and their metabolites in autopsy blood by liquid chroma-
tography–tandem mass spectrometry. Journal of Analytical
Toxicology, 31, 394–408.
16. Dahn, T., Gunn, J., Kriger, S., Terrel, A.R. (2010) Clinical applications
of mass spectrometry, methods in molecular biology, Garg, U.,
Hammett-Stabler, C.A. (eds.) Humana Press, New York, NY.
17. Coles, R., Kushnir, M.M., Nelson, G.J., McMillin, G.A., Urry, F.M.
(2007) Simultaneous determination of codeine, morphine, hydro-
codone, hydromorphone, oxycodone, and 6-acetylmorphine in
urine, serum, plasma, whole blood, and meconium by LC–MS–MS.
Journal of Analytical Toxicology, 31, 1–16.
18. Mushoff, F., Daldrup, T. (1993) Evaluation of a method for simultan-
eous quantiﬁcation of codeine, dihydrocodeine, morphine, and 6-
monoacetylmorphine in serum, blood, and postmortem blood.
International Journal of Legal Medicine, 106, 107–109.
19. Crandall, C.S., Kerrigan, S., Blau, R.L.A., LaValley, J., Zumwalt, R.,
McKinney, P.E. (2006) The inﬂuence of site of collection on post-
mortem morphine concentrations in heroin overdose victims.
Journal of Forensic Science, 51, 413–420.
20. Bezerra, M.A., Santelli, R.E., Oliveira, E.P., Villar, L.S., Escaleira, L.A.
(2008) Response surface methodology (RSM) as a tool for optimiza-
tion in analytical chemistry. Talanta, 76, 965–977.
21. Ferreira, S.L.C., Bruns, R.E., Ferreira, H.S., Matos, G.D., David, J.M.,
Branda˜o, G.C. et al. (2007) Box-Behnken design: An alternative for
the optimization of analytical methods. Analytica Chimica Acta,
597, 179–186.
22. Bruce, P., Minkkinen, P., Riekkola, M.L. (1998) Practical method val-
idation: Validation sufﬁcient for an analysis method. Mikrochimica
Acta, 128, 93–106.
23. Coombs, W.T., Algina, J., Oltman, D. (1996) Univariate and multivari-
ate omnibus hypothesis tests selected to control type I error rates
when population variances are not necessarily equal. Review of
Educational Research, 66, 137–179.
24. Almeida, A.M., Castelo-Branco, M.M., Falca˜o, A.C. (2002) Linear re-
gression for calibration lines revisited: weighting schemes for bioa-
nalytical methods. Journal of Chromatography B, 774, 215–222.
25. Chen, B.H., Taylor, E.H., Pappas, A.A. (1990) Comparison of deriva-
tives for determination of codeine and morphine by gas chroma-
tography/mass spectrometry. Journal of Analytical Toxicology,
14, 12–17.
26. Wang, P., Stone, J.A., Chen, K.H., Gross, S.F., Haller, C.A., Wu, A.H.
(2006) Incomplete recovery of prescription opioids in urine using
enzymatic hydrolysis of glucuronide metabolites. Journal of
Analytical Toxicology, 30, 570–575.
27. Hackett, L.P., Dusci, L.J., Ilett, K.F., Chiswell, G.M. (2002)
Optimizing the hydrolysis of codeine and morphine glucuronides
in urine. Therapeutic Drug Monitoring, 24, 652–657.
28. Costa, S., Barroso, M., Castan˜era, A., Dias, M. (2010) Design of
experiments, a powerful tool for method development in forensic
toxicology: Application to the optimization of urinary morphine
3-glucuronide acid hydrolysis. Analytical and Bioanalytical
Chemistry, 396, 2533–2542.
29. Romberg, L.W., Lee, L. (1995) Comparison of the hydrolysis rates of
morphine-3-glucuronide and morphine-6-glucuronide with acid
and beta-glucuronidase. Journal of Analytical Toxicology, 19,
157–162.
30. Lin, Z., Lafolie, P., Beck, O. (1994) Evaluation of analytical proce-
dures for urinary codeine and morphine measurements. Journal of
Analytical Toxicology, 18, 129–133.
31. Ropero-Miller, J.D., Lambing, M.K., Winecker, R.E. (2002)
Simultaneous quantitation of opioids in blood by GC–EI-MS analysis
following deproteination, detautomerization of keto analytes, solid-
phase extraction, and trimethylsilyl derivatization. Journal of
Analytical Toxicology, 26, 524–528.
32. Drummer, O.H. (2007) Requirements for bioanalytical procedures in
postmortem toxicology. Analytical and Bioanalytical Chemistry,
388, 1495–1503.
33. Antonides, H.M., Kiely, E.R., Marinetti, L.J. (2007) Vitreous ﬂuid
quantiﬁcation of opiates, cocaine, and benzoylecgonine:
Comparison of calibration curves in both blood and vitreous matri-
ces with corresponding concentrations in blood. Journal of
Analytical Toxicology, 31, 469–476.
170 Sanches et al.
